JRSH

Jerash Holdings (US), Inc.

69
Fundamentals78/ 100
Valuation57/ 100
Upside potential80/ 100
Risk potential10/ 100

JRSH has the edge over NIO overall, supported by stronger modeled upside and lower modeled downside.

NIO

NIO Inc.

56
Fundamentals77/ 100
Valuation50/ 100
Upside potential58/ 100
Risk potential27/ 100

NIO's outlook is improving, though it still trails on the overall score.

JRSH Fundamentals

MetricStatus
Healthy
Healthy
Stable
Strong

JRSH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.

NIO Fundamentals

MetricStatus
Strong
Stable
Stable
Unavailable

NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.

JRSH PE Valuation

CHEAPFAIREXPENSIVE14x28x42x56x
CHEAPFAIREXPENSIVE14x28x42x56x
LevelPEPriceVs current
Cheap8.4x$4.11-44%
Fair14x$6.75-8.1%
Current15x$7.35—
Forward15x$7.35—
Expensive26x$12.70+73%

Historical ranges are pointers, not guarantees.

JRSH's PE is in its fair range at 15.0x. On analysts' estimates for next year's earnings, today's price would be 15.2x.

NIO PE Valuation

NIO has no meaningful PE right now: it lost money over the past year.

JRSH Forward outlook

MetricOutlook
Stable
Strong growth
Growth
Strongly improving
Limited
High

Analysts expect earnings and revenue growth for JRSH, with profitability improving.

NIO Forward outlook

MetricOutlook
--
Losses shrinking
Growth
Strongly improving
Limited
Moderate

Analysts expect NIO's losses to shrink, with revenue growing.

JRSH Risk to reward

ScenarioChangePrice
Upside+41%$10.36
Downside-10%$6.58

Calculated from the latest close: $7.35 on Nov 12.

JRSH has a better modeled risk to reward balance than NIO, with more potential upside and less potential downside.

NIO Risk to reward

ScenarioChangePrice
Upside+38%$4.21
Downside-27%$2.22

Calculated from the latest close: $3.05 on Nov 12.

NIO trails JRSH on modeled risk to reward, with less potential upside and more potential downside.

JRSH Earnings Per Share

Q4 2023: $-0.07Q1 2024: $-0.16Q2 2024: $-0.31Q3 2024: $-0.29Q4 2024: $-0.31Q1 2025: $-0.07Q2 2025: $0.07Q3 2025: $0.06Q4 2025: $0.15Q1 2026: $0.27Q2 2026: $0.37Q3 2026: $0.49Forward: $0.49
Q4 2023: $-0.07Q1 2024: $-0.16Q2 2024: $-0.31Q3 2024: $-0.29Q4 2024: $-0.31Q1 2025: $-0.07Q2 2025: $0.07Q3 2025: $0.06Q4 2025: $0.15Q1 2026: $0.27Q2 2026: $0.37Q3 2026: $0.49Forward: $0.49
QuarterTTM EPSYoY
Forward$0.49-1%
Q3 2026$0.49+717%
Q2 2026$0.37+429%
Q1 2026$0.27+$0.34
Q4 2025$0.15+$0.46
Q3 2025$0.06+$0.35
Q2 2025$0.07+$0.38
Q1 2025-$0.07+$0.09
Q4 2024-$0.31-$0.24

JRSH has the edge over NIO on earnings quality, reporting a profit while its opponent remains loss making.

NIO Earnings Per Share

Q3 2023: $-1.93Q4 2023: $-1.87Q1 2024: $-1.82Q2 2024: $-1.64Q3 2024: $-1.61Q4 2024: $-1.66Q1 2025: $-1.76Q2 2025: $-1.74Q3 2025: $-1.59Q4 2025: $-1.06Q1 2026: $-0.60Q2 2026: $-0.29
Q3 2023: $-1.93Q4 2023: $-1.87Q1 2024: $-1.82Q2 2024: $-1.64Q3 2024: $-1.61Q4 2024: $-1.66Q1 2025: $-1.76Q2 2025: $-1.74Q3 2025: $-1.59Q4 2025: $-1.06Q1 2026: $-0.60Q2 2026: $-0.29
QuarterTTM EPSYoY
Q2 2026-$0.29+$1.45
Q1 2026-$0.60+$1.16
Q4 2025-$1.06+$0.60
Q3 2025-$1.59+$0.02
Q2 2025-$1.74-$0.10
Q1 2025-$1.76+$0.06
Q4 2024-$1.66+$0.21
Q3 2024-$1.61+$0.32

NIO is still losing money, but far less than before: $0.29 per share over the past year, against $1.93 at its worst in late 2023.

JRSH Quarterly Revenue

Q4 2023: $28MQ1 2024: $22MQ2 2024: $41MQ3 2024: $40MQ4 2024: $35MQ1 2025: $29MQ2 2025: $40MQ3 2025: $42MQ4 2025: $42MQ1 2026: $43MQ2 2026: $50MQ3 2026: $50M
Q4 2023: $28MQ1 2024: $22MQ2 2024: $41MQ3 2024: $40MQ4 2024: $35MQ1 2025: $29MQ2 2025: $40MQ3 2025: $42MQ4 2025: $42MQ1 2026: $43MQ2 2026: $50MQ3 2026: $50M
QuarterRevenueYoY
Q3 2026$50.3M+20%
Q2 2026$50.2M+27%
Q1 2026$42.9M+47%
Q4 2025$41.8M+18%
Q3 2025$42M+4.3%
Q2 2025$39.6M-3.2%
Q1 2025$29.3M+36%
Q4 2024$35.4M+29%

JRSH has the edge over NIO on sales, with stronger typical year-over-year growth.

NIO Quarterly Revenue

Q3 2023: $2.9BQ4 2023: $2.6BQ1 2024: $1.5BQ2 2024: $2.6BQ3 2024: $2.8BQ4 2024: $3BQ1 2025: $1.8BQ2 2025: $2.9BQ3 2025: $3.3BQ4 2025: $5.2BQ1 2026: $3.8BQ2 2026: $4.8B
Q3 2023: $2.9BQ4 2023: $2.6BQ1 2024: $1.5BQ2 2024: $2.6BQ3 2024: $2.8BQ4 2024: $3BQ1 2025: $1.8BQ2 2025: $2.9BQ3 2025: $3.3BQ4 2025: $5.2BQ1 2026: $3.8BQ2 2026: $4.8B
QuarterRevenueYoY
Q2 2026$4.8B+69%
Q1 2026$3.8B+112%
Q4 2025$5.2B+76%
Q3 2025$3.3B+17%
Q2 2025$2.9B+9%
Q1 2025$1.8B+21%
Q4 2024$3B+15%
Q3 2024$2.8B-2.1%

NIO's revenue has grown year over year for seven quarters in a row: $4.8B last quarter, up 69% from the same quarter a year ago.

JRSH Free Cash Flow

Q4 2023: −$500,353Q1 2024: −$6MQ2 2024: −$2MQ3 2024: $4MQ4 2024: −$3MQ1 2025: $1MQ2 2025: −$7MQ3 2025: $6MQ4 2025: −$4MQ1 2026: $2MQ2 2026: $2MQ3 2026: $4M
Q4 2023: −$500,353Q1 2024: −$6MQ2 2024: −$2MQ3 2024: $4MQ4 2024: −$3MQ1 2025: $1MQ2 2025: −$7MQ3 2025: $6MQ4 2025: −$4MQ1 2026: $2MQ2 2026: $2MQ3 2026: $4M
QuarterFree cash flowYoY
Q3 2026$4.4M-32%
Q2 2026$2.3M+$9.3M
Q1 2026$1.8M+21%
Q4 2025-$3.9M-$750.5K
Q3 2025$6.4M+46%
Q2 2025-$6.9M-$4.6M
Q1 2025$1.5M+$7.3M
Q4 2024-$3.2M-$2.7M

JRSH's free cash flow has turned positive after two years mostly in the red: $5M over the past year.

NIO Free Cash Flow

Q3 2023: --Q4 2023: $137MQ1 2024: $0Q2 2024: −$2.2BQ3 2024: $0Q4 2024: −$391MQ1 2025: $0Q2 2025: −$2.1BQ3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Q3 2023: --Q4 2023: $137MQ1 2024: $0Q2 2024: −$2.2BQ3 2024: $0Q4 2024: −$391MQ1 2025: $0Q2 2025: −$2.1BQ3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
QuarterFree cash flowYoY
Q2 2026$0+$2.1B
Q1 2026$0$0
Q4 2025$0+$391.3M
Q3 2025$0$0
Q2 2025-$2.1B+$73.9M
Q1 2025$0$0
Q4 2024-$391.3M-386%
Q2 2024-$2.2B+$337.9M

NIO's free cash flow was $0 over the past year, against −$2.5B the year before.

JRSH Total Shares

Q4 2023: 12MQ1 2024: 12MQ2 2024: 12MQ3 2024: 12MQ4 2024: 12MQ1 2025: 12MQ2 2025: 13MQ3 2025: 13MQ4 2025: 13MQ1 2026: 13MQ2 2026: 13MQ3 2026: 14M
Q4 2023: 12MQ1 2024: 12MQ2 2024: 12MQ3 2024: 12MQ4 2024: 12MQ1 2025: 12MQ2 2025: 13MQ3 2025: 13MQ4 2025: 13MQ1 2026: 13MQ2 2026: 13MQ3 2026: 14M
PeriodChange %Net change
Quarterly+0.8%+113K shares
1 year+2.5%+326K shares
3 years+9.8%+1.2M shares
5 years+17%+2M shares
Available history+18%+2.1M shares

JRSH has the edge over NIO on shareholder dilution, with a more favorable share count trend.

NIO Total Shares

Q3 2023: 1.7BQ4 2023: 1.8BQ1 2024: 2BQ2 2024: 2BQ3 2024: 2.1BQ4 2024: 2.1BQ1 2025: 2.1BQ2 2025: 2.2BQ3 2025: 2.4BQ4 2025: 2.5BQ1 2026: 2.5BQ2 2026: 2.5B
Q3 2023: 1.7BQ4 2023: 1.8BQ1 2024: 2BQ2 2024: 2BQ3 2024: 2.1BQ4 2024: 2.1BQ1 2025: 2.1BQ2 2025: 2.2BQ3 2025: 2.4BQ4 2025: 2.5BQ1 2026: 2.5BQ2 2026: 2.5B
PeriodChange %Net change
Quarterly+0.6%+15.6M shares
1 year+12%+267M shares
3 years+51%+844M shares
5 years+60%+933M shares
Available history+143%+1.5B shares

NIO has 2.5B diluted shares, up 12% from a year ago.

JRSH Net Leverage

Q4 2023: -6.4xQ1 2024: -6.6xQ3 2024: -68.9xQ4 2024: -13.3xQ1 2025: -4.6xQ2 2025: -0.3xQ3 2025: -2.6xQ4 2025: -0.7xQ1 2026: -1.2xQ2 2026: -1.1xQ3 2026: -1.3x
Q4 2023: -6.4xQ1 2024: -6.6xQ3 2024: -68.9xQ4 2024: -13.3xQ1 2025: -4.6xQ2 2025: -0.3xQ3 2025: -2.6xQ4 2025: -0.7xQ1 2026: -1.2xQ2 2026: -1.1xQ3 2026: -1.3x
QuarterNet LeverageStatus
Q3 2026-1.3xNet Cash
Q2 2026-1.1xNet Cash
Q1 2026-1.2xNet Cash
Q4 2025-0.7xNet Cash
Q3 2025-2.6xNet Cash
Q2 2025-0.3xNet Cash
Q1 2025-4.6xNet Cash
Q4 2024-13.3xNet Cash

JRSH has more cash than debt.

NIO Net Leverage

NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

JRSH Weekly Momentum

MetricValueStatus
RSI84.7Overbought
Stochastic74.8Neutral

JRSH's weekly RSI is 85 (overbought) and its Stochastic is 75 (neutral).

NIO Weekly Momentum

MetricValueStatus
RSI30.7Neutral
Stochastic6.9Oversold

NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).

JRSH PE vs Consumer Cyclical Sector

MetricJRSHSector medianRelative
PE15x18x17% below
PE %584711 pts above

JRSH is trading at 15x earnings, a 17% discount to the Consumer Cyclical sector's median of 18x.

NIO PE vs Consumer Cyclical Sector

NIO has no meaningful PE right now: it lost money over the past year.

JRSH Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$6.2118% above
20 week MA$5.5034% above
50 week MA$4.1677% above
100 week MA$3.7596% above
200 week MA$3.60104% above

JRSH has the edge over NIO on trend strength, trading above more of its moving averages.

NIO Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$3.369.2% below
20 week MA$4.0124% below
50 week MA$4.8137% below
100 week MA$4.8537% below
200 week MA$6.0349% below

NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.

JRSH Yearly ROI

YearStart priceEnd priceROI
2020$6.02$5.52-8.3%
2021$5.52$6.70+21%
2022$6.70$4.03-40%
2023$4.03$3.11-23%
2024$3.11$3.43+10%
2025$3.43$3.03-12%
2026 YTD$3.03$7.35+143%

JRSH has the edge over NIO on returns for 2026, with the stronger performance.

NIO Yearly ROI

YearStart priceEnd priceROI
2020$2.42$45.8+1791%
2021$45.8$30.5-33%
2022$30.5$11.0-64%
2023$11.0$9.07-17%
2024$9.07$4.48-51%
2025$4.48$5.10+14%
2026 YTD$5.10$3.05-40%

NIO's yearly returns have swung widely, from +1791% in 2020 to −64% in 2022. It's down 40% so far in 2026.

Give your agent the market.

Get API key